News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Ruslan Horblyuk, MBA

Articles by Ruslan Horblyuk, MBA

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study

ByWilliam H. Herman, MD, MPH,Riad G. Dirani, PhD,Ruslan Horblyuk, MBA,M. Colleen O'Neill, BSc,Barbara Kravitz, MS,Mark A. Heise, PhD,Alan Bakst, PharmD, MBA,Martin I. Freed, MD,the RESULT St

April 1st 2005

Latest Updated Articles

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study
Published: April 1st 2005 | Updated:

Trending on AJMC

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

New Dermatologic Therapies Make Waves at Maui Derm 2026

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.